Funds and ETFs Syngene International Limited

Equities

SYNGENE

INE398R01022

Biotechnology & Medical Research

Market Closed - NSE India S.E. 07:43:49 2024-04-26 am EDT 5-day change 1st Jan Change
698.6 INR -0.07% Intraday chart for Syngene International Limited -2.14% -0.41%

ETFs positioned on Syngene International Limited

Name Weight AuM 1st Jan change Investor Rating
0.02% 4 M€ -4.41% -
0.00% 117 M€ +1.11% -
0.00% 34 M€ +2.14% -
Syngene International Limited is an integrated research, development, and manufacturing services company. The Company is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Its services include drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process research and development, current good manufacturing practice (cGMP) manufacturing, formulation, and analytical development, along with clinical development services. It offers SynVent, a therapeutic discovery and development platform for executing drug discovery projects. SynVent's portfolio covers modalities and therapeutic areas ranging from small molecule inhibitors to targeted protein stabilization. It serves the pharmaceutical, biotechnology, and specialty chemical sectors, among others. It operates multi-modal biologics manufacturing facility.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
698.6 INR
Average target price
725.1 INR
Spread / Average Target
+3.80%
Consensus
  1. Stock Market
  2. Equities
  3. SYNGENE Stock
  4. Funds and ETFs Syngene International Limited